Market Place
Sourcing Support
Long Grove Pharmaceuticals Launches Premix Norepinephrine
22 May 2024 //
PR NEWSWIRE
Axsome Initiates PARADIGM Ph3 Trial of Solriamfetol for the Treatment MDD
19 Mar 2024 //
GLOBENEWSWIRE
Enforcement Report - Week of August 9, 2023
09 Aug 2023 //
FDA
Enforcement Report - Week of May 31, 2023
31 May 2023 //
FDA
Enforcement Report - Week of May 24, 2023
24 May 2023 //
FDA
Long Grove Secures Commercial Rights to an Essential Critical Care Medication
04 May 2023 //
PR NEWSWIRE
Enforcement Report - Week of May 11, 2022
11 May 2022 //
PRESS RELEASE
Enforcement Report - Week of January 5, 2022
05 Jan 2022 //
FDA
FDA Approves Baxter`s Ready-to-use Norepinephrine in Premix Formulation
23 Sep 2021 //
BUSINESSWIRE
Enforcement Report - Week of August 25, 2021
25 Aug 2021 //
FDA
Breckenridge Pharmaceutical Launches Norepinephrine Bitartrate Injection USP
20 Aug 2021 //
PRNEWSWIRE
Fine chemicals: Axyntis relocates the production of pharmaceutical active ingredients
21 May 2021 //
LESECHOS
Chimie fine : Axyntis relocalise la production d`actifs pharmaceutiques
05 May 2021 //
LESECHOS
Axsome completes patient enrollment in CONCERT ph2 trial of AXS-12 in narcolepsy
21 Oct 2019 //
PHARMABIZ
Enforcement Report - Week of May 1, 2019
01 May 2019 //
FDA
Enforcement Report - Week of December 19, 2018
19 Dec 2018 //
FDA
Axsome receives FDA Orphan Drug designation for narcolepsy drug
19 Oct 2018 //
BIOSPECTRUM ASIA
Enforcement Report - Week of September 26, 2018
26 Sep 2018 //
FDA
Theravance Biopharma Reports +ve Top-Line Four-Week Data from Ph 2 Trial
02 Aug 2018 //
PR NEWSWIRE
Enforcement Report - Week of July 25, 2018
25 Jul 2018 //
FDA
Shkreli in the stocks; still sharing biotech tips
03 Jul 2018 //
FIERCE BIOTECH
FDA approves first non-opioid to treat withdrawal symptoms in adults
18 May 2018 //
ENDPTS
Antidepressant-Migraine Drug Combination Found Less Risky Than Believed
28 Feb 2018 //
FORBES
Enforcement Report - Week of August 2, 2017
02 Aug 2017 //
FDA
Enforcement Report - Week of June 21, 2017
21 Jun 2017 //
FDA
Agilis Announces First Patient Treated in Phase IIb Clinical Study
21 Nov 2016 //
DRUG DEVELOPMENT
Here’s how trauma, sudden sounds form lasting memories in brain
25 Aug 2015 //
THE FINANCIAL EXPRESS
Recent CytoSorb® Case Reports Highlight its Use to Help Save the Lives of Critically-Ill Patients
12 Dec 2014 //
PRNEWSWIRE
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.